Hangzhou Tigermed Consulting: Listed in Hong Kong announcement - disclosure financial reports the following day.
Tiger Pharmaceuticals: Announcement on the normal production and operation of the company
Hangzhou Tigermed Consulting: Announcement of H shares - Monthly report on securities changes.
Hangzhou Tigermed Consulting: Announcement about the progress of stock repurchase.
Hangzhou Tigermed Consulting: H Share Announcement-Next Day Disclosure Statement
Hangzhou Tigermed Consulting: H Share Announcement-Next Day Disclosure Statement
Hangzhou Tigermed Consulting: H Share Announcement-Next Day Disclosure Statement
Hangzhou Tigermed Consulting: H Share Announcement-Next Day Disclosure Statement
Hangzhou Tigermed Consulting: Legal Opinions of Beijing Jiayuan Law Firm on the 2023 Annual General Meeting of Shareholders of Hangzhou Tiger Pharmaceutical Technology Co., Ltd., the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024
Hangzhou Tigermed Consulting: Announcement of the resolutions of the 2023 Annual General Meeting of Shareholders, the 2024 Second Class A Shareholders' Meeting, and the 2024 Second Class H Shareholders' Meeting
Hangzhou Tigermed Consulting: Announcement on the initial repurchase of company shares
Hangzhou Tigermed Consulting: Announcement on additional pledges and partial share repurchases and cancellation of pledges for shareholders holding 5% or more of shares
Hangzhou Tigermed Consulting: Announcement on the completion of cancellation of share repurchases and changes in shares
Hangzhou Tigermed Consulting: Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies in Zhejiang
Hangzhou Tigermed Consulting: H Share Announcement-Monthly Statement of Securities Changes
Hangzhou Tigermed Consulting: Legal opinions of the 2024 Second Extraordinary General Meeting of Shareholders, the 2024 First Class A Shareholders' Meeting, and the 2024 First Class H Shareholders' Meeting
Hangzhou Tigermed Consulting: Notice to creditors on cancellation of repurchased shares, capital reduction and addition of repurchased shares
Hangzhou Tigermed Consulting: Repurchase Report
Hangzhou Tigermed Consulting: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders, the 2024 First Class A Shareholders' Meeting, and the 2024 First Class H Shareholders' Meeting
Hangzhou Tigermed Consulting: Announcement on holding the 2023 Annual General Meeting of Shareholders, the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024
No Data